Syndax Pharmaceuticals Inc (SNDX)
Investing Cash Flow
-$16.91M
Quarterly · Period ending: · USD
SNDX Investing Cash Flow
Latest reported-$16.91Mperiod ending
Latest reported-$16.91Mperiod ending
SNDX Quarterly Cash from Investing ($0.00 → -$16.91M)
Quarterly investing cash flow
High-resolution chart · PNG
SNDX investing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -16,914,000 | |
| 38,390,000 | |
| 81,578,000 | |
| 72,429,000 | |
| 41,887,000 | |
| 94,142,000 | |
| -268,973,000 | |
| 86,847,000 | |
| 61,750,000 | |
| -99,399,000 | |
| -16,290,000 | |
| 40,077,000 | |
| 73,907,000 | |
| 19,915,000 | |
| -137,629,000 | |
| -6,793,000 | |
| -49,948,000 | |
| 8,182,000 | |
| -59,956,000 | |
| 26,631,000 | |
| 21,680,000 | |
| -29,228,000 | |
| -64,140,000 | |
| 19,275,000 | |
| -78,612,000 | |
| -19,053,000 | |
| 6,596,000 | |
| 12,364,000 | |
| -18,931,000 | |
| 12,752,000 | |
| 15,962,000 | |
| 3,508,000 | |
| 19,284,000 | |
| 12,644,000 | |
| 1,544,000 | |
| 6,921,000 | |
| -36,555,000 | |
| 11,063,000 | |
| 21,331,000 | |
| 8,050,000 | |
| -624,000 | |
| -47,137,000 | |
| -17,558,000 | |
| -7,413,000 | |
| -17,214,000 | |
| -19,484,000 | |
| -2,100,000 | |
| 0 | |
| 2,536,000 | |
| 1,452,000 | |
| -4,052,000 | |
| -8,000 | |
| 33,000 | |
| 0 | |
| 0 |